SBI JI Innovation Fund

About

Portfolio · 2

LogicBio Therapeutics

Gene Therapy for Genetic and Infectious Diseases

1 round $45.0M committed Latest: 2017-06

Argus Cyber Security

A global leader in automotive cybersecurity, providing solutions to protect connected vehicles and fleets from cyber threats.

Led ★ 1 round $26.0M committed Latest: 2015-09

Investment activity

4 portfolio exits on record.

Q&A

What is SBI JI Innovation Fund's primary investment focus?

SBI JI Innovation Fund is a biopharma-focused venture capital fund. It cherry-picks Israeli or Israel-related venture-backed biopharma companies across different developmental stages.

When was SBI JI Innovation Fund founded?

SBI JI Innovation Fund was formed in early 2017 as a partnership between SBI Holdings and Vertex.

Which sectors does SBI JI Innovation Fund primarily invest in?

SBI JI Innovation Fund primarily invests in Health Tech & Life Sciences, with some investments also in Cyber Security and Fintech & Insurtech.

Can you name some notable portfolio companies of SBI JI Innovation Fund?

Notable portfolio companies include Ayala Pharmaceuticals, which focuses on targeted therapies for rare cancers, and BiomX, which develops microbiome therapies for chronic diseases.

Has SBI JI Innovation Fund had any notable exits?

Yes, SBI JI Innovation Fund has had exits, including Chemomab Therapeutics via a Reverse Merger Event in March 2021 and Ayala Pharmaceuticals via a PO Event in May 2020.

What investment stages does SBI JI Innovation Fund typically participate in?

SBI JI Innovation Fund participates in a range of investment stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.

Who are the founding partners of SBI JI Innovation Fund?

The founding partners of SBI JI Innovation Fund include Masa Tanaka, David HELLER, and Ran Gartenberg.

What is the geographic focus of SBI JI Innovation Fund's investments?

SBI JI Innovation Fund focuses on Israeli or Israel-related venture-backed biopharma companies.